We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.
We’d also like to use analytics cookies so we can understand how you use the service and make improvements.
Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.
Platform
Biological risk management for oncology drug development.
Predict who will respond to your asset, with measured confidence.
De-risk translation and trials by simulating drug response from preclinical models to patients, and estimating benefit for every trial participant.
Point-and-click analysis of private or public datasets. Zero coding skills required.
Import once. Version & QC centrally.
Our partners leverage Concr advanced predictive modelling across every stage of therapeutic development to create shared value for the benefit of cancer patients.
Our growth is powered by funding and hands-on support from across three continents.
